Exploring the Similar Pathology “Genetic Doppelgängers” ALS and SCA36
Thor_Deichmann / Pixabay

Exploring the Similar Pathology “Genetic Doppelgängers” ALS and SCA36

Recently, scientists from Emory University set out to discover whether there was any pathological link between spinocerebellar ataxia type 36 (SCA36) and amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD). Both…

Continue Reading Exploring the Similar Pathology “Genetic Doppelgängers” ALS and SCA36
Research Links Metabolic Syndrome in Parkinson’s Patients Who Have LRRK2 Mutations
source: pixabay.com

Research Links Metabolic Syndrome in Parkinson’s Patients Who Have LRRK2 Mutations

  A recent article in Parkinson’s News Today described new findings associated with mutations in the LRRK2 gene, which are associated with Parkinson’s disease (PD). Indications are that patients with…

Continue Reading Research Links Metabolic Syndrome in Parkinson’s Patients Who Have LRRK2 Mutations
Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?
source: pixabay.com

Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?

  Biological robots, commonly known as biobots, mimic the actions of other organisms (e.g. jumping or swimming). Biobots are composed of artificial materials and also organic material. As published in…

Continue Reading Could Biobots be the Key to Understanding ALS and other Neuromuscular Diseases?
Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes
source: pixabay.com

Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes

Atypical hemolytic uremic syndrome (aHUS) is a rare condition which can be sparked by pregnancy, although it can also occur without it. Essentially, if you are genetically predisposed to the condition,…

Continue Reading Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes
Controls Needed for the Dupuytren Biomarker Discovery Pilot Study
source: pixabay.com

Controls Needed for the Dupuytren Biomarker Discovery Pilot Study

We need controls! No, not cockpit controls or videogame controls, and no, we're not out of control. We need control participants for the Dupuytren Biomarker Discovery Pilot Study. Our goal is…

Continue Reading Controls Needed for the Dupuytren Biomarker Discovery Pilot Study

Former UFC Athlete Joe Ellenberger’s Toughest Opponent: Paroxysmal Nocturnal Hemoglobinuria

The UFC has some tough fighters in it. But 35-year-old Joe Ellenberger never thought that his most difficult opponent would be within himself. That is, his paroxysmal nocturnal hemoglobinuria (PNH),…

Continue Reading Former UFC Athlete Joe Ellenberger’s Toughest Opponent: Paroxysmal Nocturnal Hemoglobinuria
Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers
source: pixabay.com

Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers

A recent BioSpace press release shares some exciting news for patients with non-small cell lung cancer, medullary thyroid cancer, and other thyroid cancers caused by RET gene mutations. Retevmo (selpercatinib) is the…

Continue Reading Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers